Absorbable Hemostat Pads Market to Reach USD 2.7 Billion by 2036, Growing at 7.5% CAGR as Hospitals Standardize Surgical Bleeding-Control Solutions

Oxidized Regenerated Cellulose Leads with 41.0% Share, Hospitals Account for 59.0% of Demand, and the United States Emerges as the Fastest-Growing Major Market at 8.2% CAGR

The global Absorbable Hemostat Pads Market is projected to expand from USD 1.3 billion in 2026 to USD 2.7 billion by 2036, registering a 7.5% CAGR during the forecast period. The market surpassed USD 1.2 billion in 2025 and is expected to generate an absolute dollar opportunity of USD 1.4 billion by 2036.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=15415

Growing surgical volumes, increasing use of adjunctive bleeding-control materials, and rising hospital standardization of absorbable hemostatic products are supporting market growth. Absorbable hemostat pads are increasingly used during general surgery, cardiovascular procedures, orthopedic interventions, and trauma care when surgeons require reliable local bleeding control without product removal after hemostasis.

Key Market Highlights at a Glance

• Market valuation in 2025: USD 1.2 billion
• Market size in 2026: USD 1.3 billion
• Forecast market size by 2036: USD 2.7 billion
• Forecast period: 2026-2036
• CAGR: 7.5%

• Absolute opportunity: USD 1.4 billion
• Leading material: Oxidized regenerated cellulose (41.0% share in 2026)
• Leading format: Pads (38.0% share in 2026)
• Leading procedure: General surgery (33.0% share in 2026)
• Leading end user: Hospitals (59.0% share in 2026)
• Fastest-growing major country: United States (8.2% CAGR)

• Key growth markets:

o United States
o Germany
o Japan
o China
o India

The absorbable hemostat pads market continues to benefit from increasing demand for ready-to-use surgical products that support capillary, venous, and small arterial bleeding control during operative procedures.
Why Is the Absorbable Hemostat Pads Market Growing?

Key Demand Drivers

• Surgeons increasingly require absorbable pads for diffuse bleeding control when suturing or cautery alone is insufficient.
• Operating room teams prefer ready-to-use hemostatic products that simplify workflow during high-pressure surgical procedures.
• Trauma centers and emergency surgical units require rapid-deployment hemostatic solutions for acute bleeding management.
• Hospital supply chain teams increasingly standardize absorbable pad formats across multiple surgical specialties.
• Growth in cardiovascular, orthopedic, neurosurgical, and general surgical procedures is driving sustained product demand.
Absorbable hemostat pads are becoming an essential surgical workflow tool because they provide direct tissue contact, support bleeding control, and eliminate the need for removal in many clinical settings.

Unlock 360° insights for strategic decision making and investment planning: https://www.factmr.com/checkout/15415

Expert Analyst Perspective

"Absorbable hemostat pads are workflow tools used during diffuse bleeding control. We see operating teams using them as workflow tools when bleeding is broad, tissue surfaces are uneven and product removal would slow closure. Suppliers that prove handling and material fit will defend stronger positions than suppliers selling only generic pads."
- Shambhu Nath Jha, Senior Analyst, Fact.MR

Which Material Leads the Absorbable Hemostat Pads Market?
Oxidized regenerated cellulose is expected to maintain market leadership due to its long-standing clinical acceptance and strong surgeon familiarity.

Segment Highlights

• Oxidized regenerated cellulose: 41.0% market share in 2026
• Widely used across multiple surgical specialties
• Easy to cut, conform, and place on irregular tissue surfaces
• Proven performance in localized bleeding control

The material remains highly preferred because it balances handling flexibility, absorbability, and broad procedural applicability.
Why Do Pad Formats Dominate Market Demand?
Pad formats are projected to remain the leading product category because they can be placed quickly and directly on bleeding surfaces without complex preparation.

Segment Highlights

• Pads: 38.0% market share in 2026
• Broad compatibility across surgical specialties
• Easy placement and trimming during procedures
• Strong adoption in hospitals and trauma settings

Pads continue to outperform alternative formats because they fit routine surgical workflows and simplify intraoperative bleeding management.

Gain Full Access to Market Forecasts and Key Drivers: https://www.factmr.com/report/absorbable-hemostat-pads-market

Which Procedure Segment Holds the Largest Share?
General surgery is expected to account for the largest share of absorbable hemostat pad utilization.

Segment Highlights

• General surgery: 33.0% market share in 2026
• High utilization in abdominal and soft-tissue procedures
• Frequent requirement for adjunctive bleeding control
• Significant procedural volume globally

General surgeons often rely on absorbable hemostatic pads when bleeding occurs on uneven tissue surfaces where conventional methods may be less effective.

Why Do Hospitals Lead Market Consumption?
Hospitals remain the dominant end-user segment because they conduct the majority of complex surgical procedures and maintain extensive inventories of bleeding-control products.

Segment Highlights

• Hospitals: 59.0% market share in 2026
• Major users across cardiovascular and orthopedic surgeries
• Strong demand from emergency and trauma departments
• Procurement standardization supporting recurring adoption
Large healthcare systems increasingly favor standardized absorbable hemostatic product portfolios to improve efficiency and inventory management.

Absorbable Hemostat Pads Market Dynamics

Market Drivers

• Increased use of adjunctive hemostats in complex surgeries
• Growing preference for ready-to-use pad and sheet formats
• Expansion of cardiovascular and orthopedic procedural volumes
• Hospital standardization of bleeding-control materials
• Rising trauma and military medical applications

Market Restraints
• Price pressure on routine surgical consumables
• Competition from sealants, powders, and flowable hemostats
• Material-related swelling and safety considerations
• Strong surgeon preference for established brands

Emerging Market Trends
• Development of layered composite absorbable pads
• Growth of chitosan- and polysaccharide-based hemostatic materials
• Expansion of procedure-specific hospital kits
• Increasing demand for ASC-ready compact pad formats
• Greater focus on handling performance and tissue conformity

Regional and Country Outlook: Which Markets Are Growing Fastest?

Country CAGR Forecasts Through 2036

• United States: 8.2%
• Germany: 7.8%
• Japan: 7.5%
• China: 7.2%
• India: 6.9%

United States
The United States is projected to record the highest growth rate among major analyzed markets at 8.2% CAGR through 2036. Growth is supported by hospital standardization programs, broad adoption of SURGICEL products, and increasing procedural volumes across general surgery, cardiovascular surgery, and orthopedics.

Germany
Germany is forecast to expand at 7.8% CAGR through 2036. Structured procurement systems, specialty surgery growth, and increasing use of adjunctive hemostatic products are supporting demand.

Japan
Japan is expected to grow at 7.5% CAGR as precision surgery programs favor predictable absorbable materials with controlled placement and absorption characteristics.

China
China is projected to advance at 7.2% CAGR through 2036. Expanding hospital surgery capacity and rising orthopedic and general surgery volumes are fueling market growth.

India
India is forecast to register a 6.9% CAGR through 2036 as private hospital networks, specialty surgical centers, and trauma-care facilities increase adoption of absorbable bleeding-control products.

Discover the Latest Insights in the Healthcare Industry: https://www.factmr.com/industry/healthcare

Competitive Landscape

Key Players in the Absorbable Hemostat Pads Market

• Johnson & Johnson - SURGICEL absorbable hemostat portfolio leadership
• Baxter - HEMOPATCH tissue sealing and hemostasis solutions
• BD - AVITENE microfibrillar collagen hemostat expertise
• Pfizer - GELFOAM sterile sponge platform
• B. Braun - Lyostypt local hemostatic agent portfolio
• Gelita Medical - oxidized cellulose and gelatin-based absorbable products
• CuraMedical - CuraSpon, CuraCel, and CuraTamp product families
• Samyang Biopharm - SurgiGuard oxidized regenerated cellulose technology

Competition is increasingly centered on material performance, surgeon trust, tissue conformity, absorption characteristics, and hospital contracting strength. Companies that demonstrate superior handling characteristics and procedure-specific clinical value are expected to outperform competitors competing primarily on price.

Frequently Asked Questions (FAQ)

What is the size of the absorbable hemostat pads market in 2026?
The global absorbable hemostat pads market is expected to be valued at USD 1.3 billion in 2026.

How large will the absorbable hemostat pads market be by 2036?
The absorbable hemostat pads market is forecast to reach USD 2.7 billion by 2036.

What is the expected CAGR of the absorbable hemostat pads market?
The absorbable hemostat pads market is projected to grow at a 7.5% CAGR from 2026 to 2036.

Which material segment leads the absorbable hemostat pads market?
Oxidized regenerated cellulose is the leading material segment and is expected to account for 41.0% of market revenue in 2026.

Which product format dominates the market?
Pads are the dominant format and are projected to capture 38.0% market share in 2026.

Which end-user segment holds the largest share?
Hospitals are the leading end-user segment and are expected to account for 59.0% of the absorbable hemostat pads market in 2026.

Who are the major companies operating in the absorbable hemostat pads market?
Major companies include Johnson & Johnson, Baxter, BD, Pfizer, B. Braun, Gelita Medical, CuraMedical, and Samyang Biopharm.

Top Trending Reports:

Absorbable Surgical Sutures Market: https://www.factmr.com/report/2674/absorbable-surgical-sutures-market
Absorbable Nonwoven Textiles Market: https://www.factmr.com/report/3349/absorbable-nonwoven-textiles-market
Bioabsorbable Stents Market: https://www.factmr.com/report/bioabsorbable-stents-market
Bioabsorbable Implant Market: https://www.factmr.com/report/bioabsorbable-implant-market

- Contact Us -
11140 Rockville Pike, Suite 400, Rockville,
MD 20852, United States
Tel: +1 (628) 251-1583 | sales@factmr.com

About Fact.MR
Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.

This release was published on openPR.